Skip to main content

Table 3 The performance of OncoUrine for diagnosis in bladder cancer (recurrence diagnosis)

From: A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

OncoUrine

Pathology

Positive

Negative

Total

Positive

8

27

35

Negative

0

58

58

Total

8

85

93

 

n/N

% (95% CI)

Sensitivity

8/8

100.0 (59.8–100.0)

Specificity

58/85

68.2 (57.1–77.7)

PPV

8/35

22.9 (11.0–40.6)

NPV

58/58

100.0 (92.3–100.0)

Kappa value

 

27.0 (11.1–42.8)

Spared cystoscopy

58/93

62.4

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us